These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 16703119

  • 1. Argatroban: a direct thrombin inhibitor with reliable and predictable anticoagulant actions.
    Escolar G, Bozzo J, Maragall S.
    Drugs Today (Barc); 2006 Apr; 42(4):223-36. PubMed ID: 16703119
    [Abstract] [Full Text] [Related]

  • 2. Argatroban.
    McKeage K, Plosker GL.
    Drugs; 2001 Apr; 61(4):515-22; discussion 523-4. PubMed ID: 11324681
    [Abstract] [Full Text] [Related]

  • 3. [Experimental and clinical results with the thrombin inhibitor Argatroban].
    Breddin HK.
    Hamostaseologie; 2002 Aug; 22(3):55-9. PubMed ID: 12215762
    [Abstract] [Full Text] [Related]

  • 4. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
    Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM, Bartholomew J, Sham R, Lerner RG, Zeigler ZR, Rustagi PK, Jang IK, Rifkin SD, Moran J, Hursting MJ, Kelton JG, ARG-911 Study Investigators.
    Circulation; 2001 Apr 10; 103(14):1838-43. PubMed ID: 11294800
    [Abstract] [Full Text] [Related]

  • 5. An overview of the direct thrombin inhibitor argatroban.
    Walenga JM.
    Pathophysiol Haemost Thromb; 2002 Apr 10; 32 Suppl 3():9-14. PubMed ID: 12811006
    [Abstract] [Full Text] [Related]

  • 6. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia.
    Dhillon S.
    Am J Cardiovasc Drugs; 2009 Apr 10; 9(4):261-82. PubMed ID: 19655821
    [Abstract] [Full Text] [Related]

  • 7. Argatroban in HIT type II and acute coronary syndrome.
    Lewis BE, Walenga JM.
    Pathophysiol Haemost Thromb; 2002 Apr 10; 32 Suppl 3():46-55. PubMed ID: 12811012
    [Abstract] [Full Text] [Related]

  • 8. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
    Boyce SW, Bandyk DF, Bartholomew JR, Frame JN, Rice L.
    Am J Ther; 2011 Jan 10; 18(1):14-22. PubMed ID: 21079512
    [Abstract] [Full Text] [Related]

  • 9. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
    Kondo LM, Wittkowsky AK, Wiggins BS.
    Ann Pharmacother; 2001 Apr 10; 35(4):440-51. PubMed ID: 11302409
    [Abstract] [Full Text] [Related]

  • 10. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE, Wallis DE, Leya F, Hursting MJ, Kelton JG, Argatroban-915 Investigators.
    Arch Intern Med; 2001 Apr 10; 163(15):1849-56. PubMed ID: 12912723
    [Abstract] [Full Text] [Related]

  • 11. Heparin-Induced Thrombocytopenia in Infants after Heart Surgery.
    Abdillah JN, Hu Q, Chen X, Chen X, Zhou W, Luo W, Huang L.
    Thorac Cardiovasc Surg; 2019 Jan 10; 67(1):21-27. PubMed ID: 29605959
    [Abstract] [Full Text] [Related]

  • 12. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
    Bartholomew JR, Pietrangeli CE, Hursting MJ.
    Drugs Aging; 2007 Jan 10; 24(6):489-99. PubMed ID: 17571914
    [Abstract] [Full Text] [Related]

  • 13. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
    Gray A, Wallis DE, Hursting MJ, Katz E, Lewis BE.
    Clin Appl Thromb Hemost; 2007 Oct 10; 13(4):353-61. PubMed ID: 17911186
    [Abstract] [Full Text] [Related]

  • 14. Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
    Matthai WH.
    Semin Thromb Hemost; 1999 Oct 10; 25 Suppl 1():57-60. PubMed ID: 10357153
    [Abstract] [Full Text] [Related]

  • 15. Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor.
    LaMonte MP, Brown PM, Hursting MJ.
    Expert Rev Cardiovasc Ther; 2005 Jan 10; 3(1):31-41. PubMed ID: 15723573
    [Abstract] [Full Text] [Related]

  • 16. Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome.
    Pendleton R, Wheeler MM, Rodgers GM.
    Ann Pharmacother; 2006 May 10; 40(5):972-6. PubMed ID: 16569813
    [Abstract] [Full Text] [Related]

  • 17. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.
    Frame JN, Rice L, Bartholomew JR, Whelton A.
    Clin Ther; 2010 Apr 10; 32(4):626-36. PubMed ID: 20435232
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH, Durkalski VL, Nappi JM.
    Pharmacotherapy; 2006 Apr 10; 26(4):461-8. PubMed ID: 16553503
    [Abstract] [Full Text] [Related]

  • 19. Pharmacology of argatroban.
    Jeske WP, Fareed J, Hoppensteadt DA, Lewis B, Walenga JM.
    Expert Rev Hematol; 2010 Oct 10; 3(5):527-39. PubMed ID: 21083469
    [Abstract] [Full Text] [Related]

  • 20. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    Reddy BV, Grossman EJ, Trevino SA, Hursting MJ, Murray PT.
    Ann Pharmacother; 2005 Oct 10; 39(10):1601-5. PubMed ID: 16131539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.